新生儿MN溶血病一例

患儿女 ,33h ,第 4胎第 2产 ,胎龄 38-1周 ,生后 18h发现皮肤黄染 ,经皮测胆红素 12 7 5 μmol/L ,逐渐加深 ,生后 33h入院。体检 :贫血貌 ,皮肤黄染 ,反应尚可 ,心肺腹无异常。实验室检查 :血常规 :WBC 17 4× 10 9/L ,N 0 5 8,L 0 4 2 ,Hb113g/L ,RBC 2 6 9× 10 12 ,PLT 16 3× 10 9/L ,Ret 0 0 5 4 ,血清总胆红素 14 2 μmol/L ,红细胞压积 0 2 5 5 (动脉血 ) ,血型血清学检查 :患儿血型 :AB ,MN ,Rh(+) ,母血型 :A ,N ,Rh(+) ,父血型 :B ,MN ,Rh(+) ;母血清不规则抗体筛选 :血清中有IgG抗M抗体 ;患儿直接抗人球蛋白…     

School achievement following hemolytic disease in the newborn

Repeated psychological investigations were performed in a group of 123 children who as newborns received exchange transfusions due to a haemolytic disease. Their school-career was compared with a control group of healthy newborns at an age of 16 years. In the Mhn-group a lower level of school performance could be observed. There was a higher percentage of backward children according to additional perinatal risks and a lower socioeconomic status of the parents. Even at the same class the two groups differed in their median school marks for the different subjects and behaviour proving the Mhn-children in spite of early exchange transfusion at risk for later failure in school.     

Severe late anemia of hemolytic disease of the newborn

Late anemia is a well-recognized complication of Rhesus hemolytic disease of the newborn (HDN). The incidence of Rhesus HDN is declining, with a tendency for more severely affected pregnancies to be managed in specialist centres. Consequently, many paediatric departments may see relatively few affected infants with comparatively mild disease, and the risk of late anemia in such cases may not always be appreciated. Two cases of infants born with evidence of Rhesus isoimmunization noted at birth and encountering no immediate problems other than mild hyperbilirubinemia are described. After an uneventful early neonatal course, both infants were discharged without follow-up and presented in the second to third weeks of life with severe, life-threatening anemia, leading to neurological sequelae in one case. The importance of close surveillance, including hemoglobin measurements, in all infants with Rhesus hemolytic disease, irrespective of initial severity, is reiterated.